Adam Rubinstein, MD
Pediatrics · Wappingers Falls, NYNPI 1174588909
Payments from drug & device makers
Across 235 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$689
- AbbVie$646
- Pfizer$571
- GSK$542
- Lilly USA, LLC$300
- Merck$183
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,253100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 46 | $689 |
| AbbVie(2 entities) | 35 | $646 |
| Pfizer | 33 | $571 |
| GSK | 25 | $542 |
| Lilly USA, LLC | 16 | $300 |
| Merck | 11 | $183 |
| Exact Sciences | 6 | $146 |
| Sanofi-aventis U.S. LLC | 7 | $146 |
| Bayer | 7 | $140 |
| AstraZeneca | 8 | $117 |
| Boehringer Ingelheim | 5 | $103 |
| Antares Pharma, Inc. | 5 | $88 |
| Amgen | 4 | $79 |
| Insulet Corporation | 3 | $60 |
| Johnson & Johnson | 3 | $59 |
| Grifols USA, LLC | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Novartis | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Gilead | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Abbott | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$250
How this compares
$4,253 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $125,078 |
| Tresiba Flextouch U-200Insulin Degludec | 92 | $103,650 |
| JardianceEmpagliflozin | 93 | $100,828 |
| EliquisApixaban | 49 | $63,671 |
| JanuviaSitagliptin Phosphate | 44 | $52,743 |
| FarxigaDapagliflozin Propanediol | 35 | $43,238 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $40,848 |
| Sumatriptan Succinate | 23 | $37,370 |
| Bydureon BciseExenatide Microspheres | 16 | $21,546 |
| Repatha SureclickEvolocumab | 14 | $21,167 |
| TradjentaLinagliptin | 18 | $19,756 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $15,155 |
| XareltoRivaroxaban | 13 | $14,587 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $13,860 |
| NexletolBempedoic Acid | 11 | $11,092 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $103 | $126,538123 claims |
| Novo NordiskOzempic | $689 | $125,07894 claims |
| MerckJanuvia, Janumet | $183 | $66,60359 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $542 | $66,49195 claims |
| PfizerEliquis | $571 | $63,67149 claims |
| AstraZenecaFarxiga | $117 | $43,23835 claims |
| Johnson & JohnsonXarelto | $59 | $14,58713 claims |
| Esperion Therapeutics, Inc.Nexletol | $29 | $11,09211 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $6,691389 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,055 pediatrics providers in New York.
Other pediatrics in Wappingers Falls
- Giancarlo GuidoBronx$3.9M
- Janet CaseyRochester$3.4M
- Michael PichicheroRochester$1.5M
- Rudolph LeibelNew York$1M
- Philip OzuahBronx$1M
- Kevin CurranNew York$842K
- Joan Decelie-GermanaGreat Neck$840K
- Shakeel ModakNew York$774K
- Elaine AbramsNew York$637K
- Dawn WaheziBronx$444K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.